CTSO
Cytosorbents Corp
Halal Rating :
Last Price
$1.03
Last updated:
Market Cap
-
7D Change
-1.9%
1 Year Change
9.57%
Company Overview
Industries
Exchange
Next Earnings Date
CytoSorbents Corporation is a critical care immunotherapy and blood purification technology company. Their flagship product, CytoSorb®, is a blood purification technology designed to reduce deadly inflammation in critically ill and cardiac surgery patients. The company develops and commercializes blood purification therapies to treat patients in intensive care units with conditions like sepsis, acute respiratory distress syndrome, and other life-threatening conditions.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $9.39m | $13.79m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $9.89m | $13.31m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $9.79m | $14.71m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Cytosorbents Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.